Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

130 ARTÍCULOS , VIENDO DEL 1 AL 15

Three-week nutritional supplementation effect on long-term nutritional status of patients with mild Alzheimer disease

de Sousa OL, Amaral TF.

Alzheimer Dis Assoc Disord. 2012 Apr-Jun;26(2):119-23. doi: 10.1097/WAD.0b013e31822c5bb3.

Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study

Hansson O, Stomrud E, Vanmechelen E, Östling S, Gustafson DR, Zetterberg H, Blennow K, Skoog I.

J Alzheimers Dis. 2012;28(1):231-8. doi: 10.3233/JAD-2011-111418.

Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia

Nielsen HM, Palmqvist S, Minthon L, Londos E, Wennström M.

Curr Alzheimer Res. 2012 Mar;9(3):257-66. doi: 10.2174/156720512800107537.

Linking atherosclerosis to Alzheimer's disease: focus on biomarkers

Emanuele E, Martinelli V, Abbiati V, Ricevuti G.

Front Biosci (Elite Ed). 2012 Jan 1;4(2):700-10. doi: 10.2741/e411.

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O.

Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155.

Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics

Bakulski KM, Rozek LS, Dolinoy DC, Paulson HL, Hu H.

Curr Alzheimer Res. 2012 Jun;9(5):563-73. doi: 10.2174/156720512800617991.

Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation

Proitsi P, Lupton MK, Dudbridge F, Tsolaki M, Hamilton G, Daniilidou M, Pritchard M, Lord K, Martin BM, Johnson J, Craig D, Todd S, McGuinness B, Hollingworth P, Harold D, Kloszewska I, Soininen H, Mecocci P, Velas B, Gill M, Lawlor B, Rubinsztein DC, Brayne C, Passmore PA, Williams J, Lovestone S, Powell JF.

Neurobiol Aging. 2012 Aug;33(8):1843.e9-17. doi: 10.1016/j.neurobiolaging.2011.12.036. Epub 2012 Feb 1.

[Review in geriatric medicine 2011]

Rochat S, Doser N, Eyer S, Jabri A, Rubli E, Büla C.

Rev Med Suisse. 2012 Jan 11;8(323):23-7.

Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison

Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB; EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative.

J Nucl Med. 2012 Apr;53(4):592-600. doi: 10.2967/jnumed.111.094946. Epub 2012 Feb 17.

Longitudinal plasma amyloid beta as a biomarker of Alzheimer's disease

Rissman RA, Trojanowski JQ, Shaw LM, Aisen PS.

J Neural Transm (Vienna). 2012 Jul;119(7):843-50. doi: 10.1007/s00702-012-0772-4. Epub 2012 Feb 22.

Family history and APOE-4 genetic risk in Alzheimer's disease

Donix M, Small GW, Bookheimer SY.

Neuropsychol Rev. 2012 Sep;22(3):298-309. doi: 10.1007/s11065-012-9193-2. Epub 2012 Feb 23.

Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing

Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ.

J Alzheimers Dis. 2012;30(2):323-36. doi: 10.3233/JAD-2012-120058.

[Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?]

Kovacs J, Pakaski M, Juhasz A, Feher A, Drotos G, Fazekas CO, Horvath TL, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Mar;14(1):19-27.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P; Alzheimer’s Disease Cooperative Study.

Arch Neurol. 2012 Jul;69(7):836-41. doi: 10.1001/archneurol.2012.85.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias